Arcus Biosciences Inc (RCUS)
17.16
+0.72
(+4.38%)
USD |
NYSE |
Dec 04, 13:50
Arcus Biosciences Price: 17.16 for Dec. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Dec 03, 2024 | 15.63 | 16.63 | 15.63 | 16.44 | 697152.0 |
| Dec 02, 2024 | 15.32 | 16.05 | 15.13 | 15.94 | 610712.0 |
| Nov 29, 2024 | 15.85 | 15.85 | 15.41 | 15.44 | 321542.0 |
| Nov 27, 2024 | 15.77 | 16.39 | 15.56 | 15.80 | 553424.0 |
| Nov 26, 2024 | 14.39 | 16.60 | 14.36 | 15.79 | 1.075M |
| Nov 25, 2024 | 14.95 | 15.40 | 14.55 | 14.56 | 813441.0 |
| Nov 22, 2024 | 14.29 | 15.07 | 14.20 | 14.70 | 534476.0 |
| Nov 21, 2024 | 14.71 | 14.71 | 14.15 | 14.28 | 676303.0 |
| Nov 20, 2024 | 14.47 | 15.01 | 14.26 | 14.62 | 597904.0 |
| Nov 19, 2024 | 14.29 | 14.77 | 14.19 | 14.51 | 355755.0 |
| Nov 18, 2024 | 15.49 | 15.73 | 14.35 | 14.43 | 685630.0 |
| Nov 15, 2024 | 15.89 | 16.05 | 14.90 | 15.70 | 923670.0 |
| Nov 14, 2024 | 16.14 | 16.48 | 15.67 | 15.77 | 472649.0 |
| Nov 13, 2024 | 16.87 | 17.21 | 16.30 | 16.43 | 563121.0 |
| Nov 12, 2024 | 17.37 | 17.76 | 16.74 | 16.77 | 442253.0 |
| Nov 11, 2024 | 18.04 | 18.98 | 17.63 | 17.75 | 1.121M |
| Nov 08, 2024 | 16.47 | 17.92 | 16.41 | 17.85 | 1.114M |
| Nov 07, 2024 | 16.13 | 16.75 | 15.30 | 16.46 | 2.495M |
| Nov 06, 2024 | 16.23 | 16.43 | 15.24 | 15.73 | 1.017M |
| Nov 05, 2024 | 15.41 | 15.50 | 15.03 | 15.29 | 537020.0 |
| Nov 04, 2024 | 15.24 | 16.00 | 15.07 | 15.56 | 590512.0 |
| Nov 01, 2024 | 15.43 | 15.78 | 15.19 | 15.50 | 814470.0 |
| Oct 31, 2024 | 16.01 | 16.13 | 15.00 | 15.30 | 508293.0 |
| Oct 30, 2024 | 16.27 | 16.71 | 15.96 | 16.00 | 352991.0 |
| Oct 29, 2024 | 16.33 | 17.23 | 16.18 | 16.41 | 854953.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.79
Minimum
Dec 05 2019
48.47
Maximum
Nov 23 2021
23.44
Average
21.66
Median
Jun 15 2022
Price Benchmarks
| Merck & Co Inc | 101.53 |
| Regeneron Pharmaceuticals Inc | 749.56 |
| NovaBay Pharmaceuticals Inc | 0.60 |
| Palatin Technologies Inc | 0.98 |
| iBio Inc | 2.64 |
Price Related Metrics
| PS Ratio | 5.610 |
| Price to Book Value | 2.779 |
| Earnings Yield | -18.36% |
| Market Cap | 1.570B |